Following its deal with Vogue, Johnson & Johnson is back in investment mode. Ci:z Holdings is entering into a partnership with Johnson & Johnson, allowing the subsidiary of the U.S. company to become Tokyo based Ci:z’s second-leading shareholder.
The move strengthens Johnson & Johnson’s Neutrogena skin care business; the investment in Ci:z will broaden sales in China and Taiwan and later expand sales routes into the United States and Europe.
According to the Nikkei Asian Review, the maker of Dr. Ci:Labo cosmetics, Ci:z Holdings, has entered into a capital and business partnership with Johnson & Johnson. A subsidiary of Johnson & Johnson will purchase 19.9% of Ci:z, making it the second-largest shareholder.
The founder and chairman, Yoshinori Shirono, will be selling a portion of his stake along with stock warrants that will procure up to $34 million. In exchange, Johnson & Johnson will transfer two board members to Ci:z. Also, Johnson & Johnson will give Ci:z the U.S. sales rights for its main cosmetics line.